Skip to main content
Mark Metzl, MD, Cardiology, Evanston, IL

Mark David Metzl MD

Adult Congenital Heart Disease, Cardiac Electrophysiology


Section Chief, Cardiac Electrophysiology

Join to View Full Profile
  • 1000 Central StSte 730Evanston, IL 60201

  • Phone+1 847-663-8410

  • Fax+1 847-570-1865

Dr. Metzl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Clinical Cardiac Electrophysiology, 2010 - 2011
  • Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)
    Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2007 - 2010
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2004

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2010 - 2026
  • NY State Medical License
    NY State Medical License 2006 - 2011
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Clinical Cardiac Electrophysiology
    American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Keeping the Beat
    Keeping the BeatSeptember 10th, 2019
  • Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-Related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation Procedures
    Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-Related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation ProceduresSeptember 15th, 2023
  • Clinical and Operational Benefits of an Electronic Medical Record Alert for Patients with Cardiac Implantable Electronic Device Infection
    Clinical and Operational Benefits of an Electronic Medical Record Alert for Patients with Cardiac Implantable Electronic Device InfectionDecember 1st, 2023
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: